At RDD Europe 2025, Dr Heather Jameson presented our poster on carrier-based formulation delivery using our Quattrii DPI platform.
In her poster, which was co-authored alongside CHI's CEO David Harris, Heather highlighted that Quattrii detaches the API from the carrier particles and retains the carrier fraction within the blister, delivering only the aerosolised active dose to the lung.
You can watch a short presentation of her poster here:
You can download a PDF copy of the poster here.